{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "GMP cyclique : Questions médicales les plus fréquentes",
"headline": "GMP cyclique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les GMP cyclique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-08",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "GMP cyclique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Nucléotides guanyliques",
"url": "https://questionsmedicales.fr/mesh/D006150",
"about": {
"@type": "MedicalCondition",
"name": "Nucléotides guanyliques",
"code": {
"@type": "MedicalCode",
"code": "D006150",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.695.827.426"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dibutyryl GMP cyclique",
"alternateName": "Dibutyryl Cyclic GMP",
"url": "https://questionsmedicales.fr/mesh/D003995",
"about": {
"@type": "MedicalCondition",
"name": "Dibutyryl GMP cyclique",
"code": {
"@type": "MedicalCode",
"code": "D003995",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.695.827.426.160.325"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "GMP cyclique",
"alternateName": "Cyclic GMP",
"code": {
"@type": "MedicalCode",
"code": "D006152",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ute Römling",
"url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Fengyang Li",
"url": "https://questionsmedicales.fr/author/Fengyang%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Zhijian J Chen",
"url": "https://questionsmedicales.fr/author/Zhijian%20J%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology , Howard Hughes Medical Institute , Department of Immunology , and Animal Resource Center , University of Texas Southwestern Medical Center , Dallas 75390-9148 , Texas , United States."
}
},
{
"@type": "Person",
"name": "Roshni R Kharadi",
"url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, MI, United States."
}
},
{
"@type": "Person",
"name": "George W Sundin",
"url": "https://questionsmedicales.fr/author/George%20W%20Sundin",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, MI, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/36342984",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/130366"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36927130",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547231161531"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pragmatic Deficits in Attention Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis.",
"datePublished": "2023-03-28",
"url": "https://questionsmedicales.fr/article/36975307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547231161534"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oculomotor deficits in attention deficit hyperactivity disorder: a systematic review and meta-analysis.",
"datePublished": "2022-10-24",
"url": "https://questionsmedicales.fr/article/36280758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02284-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterizing the metabolomic signature of attention-deficit hyperactivity disorder in twins.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37100381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuropharm.2023.109562"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléotides",
"item": "https://questionsmedicales.fr/mesh/D009711"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ribonucléotides",
"item": "https://questionsmedicales.fr/mesh/D012265"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nucléotides guanyliques",
"item": "https://questionsmedicales.fr/mesh/D006150"
},
{
"@type": "ListItem",
"position": 6,
"name": "GMP cyclique",
"item": "https://questionsmedicales.fr/mesh/D006152"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : GMP cyclique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur GMP cyclique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur GMP cyclique",
"description": "Comment mesurer le GMP cyclique dans le corps ?\nQuels tests diagnostiques sont utilisés pour le GMPc ?\nLe GMPc est-il impliqué dans des maladies spécifiques ?\nQuels biomarqueurs sont liés au GMPc ?\nComment le GMPc est-il lié à la fonction cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur GMP cyclique",
"description": "Quels symptômes sont associés à des niveaux bas de GMPc ?\nDes niveaux élevés de GMPc provoquent-ils des symptômes ?\nLe GMPc affecte-t-il la pression artérielle ?\nQuels symptômes neurologiques sont liés au GMPc ?\nLe GMPc influence-t-il la fonction rénale ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur GMP cyclique",
"description": "Comment maintenir des niveaux sains de GMPc ?\nLe stress affecte-t-il le GMPc ?\nY a-t-il des habitudes à éviter pour le GMPc ?\nL'exercice physique influence-t-il le GMPc ?\nLes suppléments peuvent-ils affecter le GMPc ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur GMP cyclique",
"description": "Quels médicaments augmentent le GMPc ?\nComment le GMPc est-il ciblé dans le traitement des maladies ?\nLe GMPc a-t-il un rôle dans la thérapie génique ?\nQuels effets secondaires sont liés aux traitements du GMPc ?\nLe GMPc est-il impliqué dans des traitements expérimentaux ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur GMP cyclique",
"description": "Quelles complications sont liées à des niveaux anormaux de GMPc ?\nLe GMPc est-il impliqué dans des maladies chroniques ?\nDes niveaux élevés de GMPc peuvent-ils causer des problèmes ?\nLe GMPc est-il lié à des troubles métaboliques ?\nComment le GMPc affecte-t-il la santé mentale ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur GMP cyclique",
"description": "Quels facteurs augmentent le risque d'anomalies de GMPc ?\nL'alimentation influence-t-elle le GMPc ?\nLe vieillissement affecte-t-il le GMPc ?\nLe manque d'exercice influence-t-il le GMPc ?\nLes maladies héréditaires affectent-elles le GMPc ?",
"url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le GMP cyclique dans le corps ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc peut être mesuré par des tests biochimiques dans des échantillons de sang ou de tissus."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés pour le GMPc ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'immunoessai et des dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il impliqué dans des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de GMPc sont associés à des maladies cardiovasculaires et neurologiques."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont liés au GMPc ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc est souvent mesuré en relation avec d'autres biomarqueurs comme le NO et les prostaglandines."
}
},
{
"@type": "Question",
"name": "Comment le GMPc est-il lié à la fonction cardiaque ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc régule la relaxation des muscles cardiaques, influençant la fonction cardiaque globale."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à des niveaux bas de GMPc ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux bas peuvent entraîner des problèmes de vasodilatation et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Des niveaux élevés de GMPc provoquent-ils des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent causer des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Le GMPc affecte-t-il la pression artérielle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le GMPc joue un rôle dans la régulation de la pression artérielle par la vasodilatation."
}
},
{
"@type": "Question",
"name": "Quels symptômes neurologiques sont liés au GMPc ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de GMPc peuvent être associées à des troubles neurologiques comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Le GMPc influence-t-il la fonction rénale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le GMPc est impliqué dans la régulation de la fonction rénale et de la filtration glomérulaire."
}
},
{
"@type": "Question",
"name": "Comment maintenir des niveaux sains de GMPc ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et l'hydratation peuvent aider à maintenir des niveaux sains."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le GMPc ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut réduire les niveaux de GMPc, affectant la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter pour le GMPc ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et une consommation excessive d'alcool peut aider à maintenir des niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il le GMPc ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut augmenter les niveaux de GMPc et améliorer la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils affecter le GMPc ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer positivement les niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le GMPc ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de la phosphodiestérase, comme le sildénafil, augmentent les niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "Comment le GMPc est-il ciblé dans le traitement des maladies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le GMPc est ciblé pour traiter des maladies cardiovasculaires et pulmonaires par des vasodilatateurs."
}
},
{
"@type": "Question",
"name": "Le GMPc a-t-il un rôle dans la thérapie génique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches de thérapie génique visent à moduler les niveaux de GMPc pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont liés aux traitements du GMPc ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des maux de tête, des rougeurs et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il impliqué dans des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches explorent l'utilisation de GMPc dans des traitements pour des cancers et des maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à des niveaux anormaux de GMPc ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux peuvent entraîner des complications cardiovasculaires et neurologiques graves."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il impliqué dans des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres de GMPc sont associés à des maladies chroniques comme l'hypertension."
}
},
{
"@type": "Question",
"name": "Des niveaux élevés de GMPc peuvent-ils causer des problèmes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent être liés à des troubles de la vision et des migraines."
}
},
{
"@type": "Question",
"name": "Le GMPc est-il lié à des troubles métaboliques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de GMPc peuvent contribuer à des troubles métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Comment le GMPc affecte-t-il la santé mentale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres de GMPc sont associés à des troubles de l'humeur et à l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies de GMPc ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'obésité et le stress chronique augmentent le risque d'anomalies de GMPc."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le GMPc ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut nuire aux niveaux de GMPc."
}
},
{
"@type": "Question",
"name": "Le vieillissement affecte-t-il le GMPc ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une diminution des niveaux de GMPc, affectant la santé globale."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice influence-t-il le GMPc ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut réduire les niveaux de GMPc et augmenter les risques cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les maladies héréditaires affectent-elles le GMPc ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent perturber la signalisation du GMPc, augmentant les risques de complications."
}
}
]
}
]
}
To assess attachment styles among adolescents (13-16 years) with ADHD or ADHD and oppositional defiant disorders (ODD)....
The Parents and Peers Attachment (IPPA) and the Parent Bonding Questionnaire (PBI) were used in three groups of teenagers raised in biological families: (1) ADHD/ODD group (n = 40), (2) ADHD group (n ...
Parental attachment styles in the area of "Trust", "Communication" and "Alienation" (IPPA), and "Care" and "Control" (PBI) in the ADHD/ODD group differ significantly compared to the control group. Tee...
The attachment style is significantly different in adolescents diagnosed with ADHD and ODD than in adolescents with only ADHD. In the ADHD/ODD group and the ADHD group, unlike in the group of adolesce...
To estimate the prevalence of PDs according to Millon's evolution-based model among adult ADHD outpatients....
Cross-sectional study of consecutive patients referred to an adult ADHD clinic. PDs were evaluated with Millon Clinical Multiaxial Inventory-III (MCMI-III)....
One-hundred-eighty-one participants had valid MCMI-III, of whom147 were diagnosed with ADHD. Mean age: 32.97, SD:11.56, females: 74 (50.3%). Among the 147 participants with ADHD, 29 (19.7%) did not me...
Particular personality profiles were more common with different ADHD subtypes. Given the developmental origins of PD, further research may help identify possible links with childhood difficulties....
While poorer pragmatic language skills have been found in attention-deficit/hyperactivity disorder (ADHD) populations, there has been no conclusive evidence of this. We aimed to conduct a meta-analysi...
Studies were identified using the search terms ((attention deficit) OR (adhd)) AND (pragmatics), and those studies were screened and reviewed for inclusion criteria, descriptive information, and outco...
A total of 14 studies (5,772 participants) met the criteria for quantitative synthesis. Meta-analysis indicated that ADHD populations exhibited significantly poorer pragmatic language skills than TD p...
It is suggested that pragmatic language skills may deserve greater surveillance considering the importance of pragmatic language in socio-emotional development, daily life, and academic success....
There is equivocal evidence on the presence of oculomotor deficits among children with attention deficit hyperactivity disorder (ADHD), which can be an additional challenge in this population, especia...
Emerging evidence implicate the gut microbiota as a potential susceptibility factor in attention-deficit hyperactivity disorder (ADHD), a common multifactorial neurodevelopmental condition. However, l...
Comorbidities are common in children with epilepsy, with nearly half of the patients having at least one comorbidity. Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder characte...
Rates of cannabis use have been rising in the US due to the increasing legalization/decriminalization of cannabis products for medical and recreational use. Individuals with attention-deficit hyperact...
People with attention deficit and hyperactivity disorder (ADHD) present attentional and emotional deficits and show paradoxical qualities such as hyperfocus. Previous studies have reported errors, slo...
Thirty French children and teenagers, 15 with ADHD and 15 neurotypical (NT), underwent a saccadic eye movement task. We conducted conventional analysis (movement duration, precision, velocity, RT) and...
Saccade duration and velocity failed to differentiate the two groups, whereas amplitude was higher in ADHD than in NT participants. Saccade RT and variability were higher in ADHD than in NT participan...
ADHD disrupts two mechanisms of action: it reduces the gain of the decision signal, thus explaining slowness and variability; it quickens the decision process of early responses at the origin of short...
These premises and their interconnections explain previous observations and support the striatal-frontal wiring of ADHD, thus explaining ADHD complexity in its negative and positive manifestations....
The association between attention-deficit/hyperactivity disorder (ADHD) and schizophrenia has received increased attention; however, evidence on the association between psychiatric comorbidities and s...
To investigate the risk of being diagnosed with schizophrenia in children and adolescents with ADHD considering the presence of psychiatric comorbidity....
This was a population-based, retrospective cohort study using the Health Insurance Review and Assessment claims database from January 1, 2007, to December 31, 2019. Participants were children and adol...
The presence of psychiatric comorbidity was assessed from diagnosis records within 1 year before ADHD diagnosis. Comorbidities were further categorized according to the number of comorbidities and spe...
Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs, examining the association between psychiatric comorbidities and the risk of being diagnosed with schizophrenia. Fu...
A total of 211 705 patients with newly diagnosed ADHD were included. A total of 157 272 patients (74.3%) were male, and the age of 5 to 9 years showed the highest distribution (115 081 patients [54.4%...
In this retrospective cohort study involving children and adolescents with ADHD, the presence of psychiatric comorbidity in patients with ADHD was associated with an increased risk of being diagnosed ...
This article explores the detection of Attention Deficit Hyperactivity Disorder, a neurobehavioral disorder, from electroencephalography signals. Due to the unstable behavior of electroencephalography...